Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner
Cardiovascular Research · 2024
DOI: 10.1093/cvr/cvae125 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Yong Wang und 21 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität Munich, Pettenkoferstr. 9, 80336 Munich, Germany. Hauptthemen laut MEDLINE: Atherosclerosis, Cell Proliferation, Disease Models, Animal, Macrophages. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Ministry of Research and Education, LMU Medical Faculty FöFoLe program.
Abstract (Originalsprache)
Aims
Although the cannabinoid CB1 receptor has been implicated in atherosclerosis, its cell-specific effects in this disease are not well understood. To address this, we generated a transgenic mouse model to study the role of myeloid CB1 signalling in atherosclerosis. Methods and results Here, we report that male mice with myeloid-specific Cnr1 deficiency on atherogenic background developed smaller lesions and necrotic cores than controls, while only minor genotype differences were observed in females. Male Cnr1-deficient mice showed reduced arterial monocyte recruitment and macrophage proliferation with less inflammatory phenotype. The sex-specific differences in proliferation were dependent on oestrogen receptor (ER)α-oestradiol signalling. Kinase activity profiling identified a CB1-dependent regulation of p53 and cyclin-dependent kinases. Transcriptomic profiling further revealed chromatin modifications, mRNA processing, and mitochondrial respiration among the key processes affected by CB1 signalling, which was supported by metabolic flux assays. Chronic administration of the peripherally restricted CB1 antagonist JD5037 inhibited plaque progression and macrophage proliferation, but only in male mice. Finally, CNR1 expression was detectable in human carotid endarterectomy plaques and inversely correlated with proliferation, oxidative metabolism, and inflammatory markers, suggesting a possible implication of CB1-dependent regulation in human pathophysiology.
Conclusion
Impaired macrophage CB1 signalling is atheroprotective by limiting their arterial recruitment, proliferation, and inflammatory reprogramming in male mice. The importance of macrophage CB1 signalling appears to be sex-dependent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität Munich, Pettenkoferstr. 9, 80336 Munich, Germany.
- Institute for Molecular Cardiovascular Research (IMCAR), Aachen-Maastricht Institute for CardioRenal Disease (AMICARE) and Interdisciplinary Center for Clinical Research (IZKF), RWTH Aachen University, Aachen, Germany.
- DZHK (German Center for Cardiovasular Research), partner site Munich Heart Alliance, Pettenkoferstr. 9, 80336 Munich, Germany.
- Institute for Diabetes and Cancer, Helmholtz Zentrum Munich, Neuherberg, Germany.
- Department of Molecular Metabolism & Sabri Ülker Center for Metabolic Research, Harvard T.H. Chan School of Public Health, Boston, USA.
- Department of Vascular and Endovascular Surgery, Klinikum rechts der Isar-Technical University Munich (TUM), Munich, Germany.
ORCID-Profile: Emiel P C van der Vorst, Alexander Bartelt, Beat Lutz, Christian Weber, Sabine Steffens
Förderung
- Deutsche Forschungsgemeinschaft
- German Ministry of Research and Education
- LMU Medical Faculty FöFoLe program
- Interdisciplinary Center for Clinical Research
- RWTH Aachen University
- Fritz Thyssen Stiftung
- Chinese Scholar Council
Zitieren
APA
Wang, Y., Li, G., Chen, B., Shakir, G., Volz, M., van der Vorst, E. P. C., Maas, S. L., Geiger, M., Jethwa, C., Bartelt, A., Li, Z., Wettich, J., Sachs, N., Maegdefessel, L., Nazari Jahantigh, M., Hristov, M., Lacy, M., Lutz, B., Weber, C., …, & Steffens, S. (2024). Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae125
Vancouver
Wang Y, Li G, Chen B, Shakir G, Volz M, van der Vorst EPC, et al. Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae125
BibTeX
@article{Wang2024,
author = {Wang, Yong and Li, Guo and Chen, Bingni and Shakir, George and Volz, Mario and van der Vorst, Emiel P C and Maas, Sanne L and Geiger, Martina and Jethwa, Carolin and Bartelt, Alexander and Li, Zhaolong and Wettich, Justus and Sachs, Nadja and Maegdefessel, Lars and Nazari Jahantigh, Maliheh and Hristov, Michael and Lacy, Michael and Lutz, Beat and Weber, Christian and Herzig, Stephan and Guillamat Prats, Raquel and Steffens, Sabine},
title = {Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner},
journal = {Cardiovascular Research},
year = {2024},
doi = {10.1093/cvr/cvae125}
}
EUVIMED